Muse monetization appears on pace to scale faster than previous product cycles, improving Meta's long-term outlook. Mizuho raised its price target to $950 from $750, while noting shares may struggle to work meaningfully into a potential early-2027 equity raise and face some cost overhang. x.com 

Meta's strong core growth and low valuation make the reaction to possible Muse dilution look excessive. Revenue grew 26%; North America grew nearly 33% where Muse, Meta One and advanced ads rolled out, a playbook Meta will extend as compute grows. Shares trade at a low-to-mid-teens multiple of ex-Muse/FRL earnings, or ~19x EPS fully capitalizing those investments. A hypothetical $100B raise with zero return might cost 6% of equity value in the most punitive case; Muse's ROI is still a bet. x.com  … Show more

A small advertising beat may not sustain Meta's stock after earnings if Muse cannot show durable use and paying customers to justify rising AI spending. Muse could monetize Meta's existing merchant base through subscriptions and more ad spend, but service costs and whether users keep paying remain unproven. Strong fourth-quarter guidance or firmer Muse usage and payment data would make the outlook more positive; September's rally alone does not establish a sell-the-news outcome. x.com 

Meta's limited dilution and Muse's potential agent revenue make its valuation hit look excessive. Even if all cash is burned without return, a $625 strike and $28.75B forward sale including the greenshoe imply 69M shares, or 2.7% gross dilution; estimated net dilution is 0.25%. A future $60B net raise is expected to dilute by much less than 1%. Muse reached 5M downloads and 1,500 connectors in 22 days; its agents could need 25GW of internal compute depending on how many 100M users it adds. x.com  … Show more

Meta's valuation is compelling again because its operating-cash-flow multiple has fallen while revenue growth accelerated over the past year. It trades at 12x operating cash flow, close to 10x 2027 operating cash flow. Its unique position should make it one of the AI era's biggest winners, with Muse becoming its best asset in the long run. The equity raise's timing was unwelcome, but that is now behind it. x.com 

Meta's spending to support Muse and its frontier models is likely to precede monetization, leaving the stock vulnerable to high initial 2027 expense and capex guidance. A beat-and-raise quarter is expected, but the stock could react poorly to that guidance after its recent strong performance. x.com 

Meta's strong core platform matters most, outweighing the Muse debate and a few years of cash flow. Muse will sort itself out; at worst, new product offerings raise the table stakes and thereby secure the platform moat. x.com 

Meta's 26% growth and still-unmonetized Muse make the dip buyable. ZeroHedge estimates $250 billion of AI capex next year; Meta would not spend that much unless Muse continues to unlock a massive opportunity in personal AI agents. x.com  x.com 

Meta's hundreds-of-gigawatts compute ambition looks hard to justify against the revenue a much smaller build might support. If Anthropic can generate over $70B in annualized revenue on 3GW or less, including training, hundreds of gigawatts is not a serious figure. Earlier Muse monetization than in past product cycles also makes little sense without direct integration into ad recommendations or an immediate shift in user behavior. x.com 

Meta's growth and earnings make its valuation appealing. It trades at 17x 2027 estimates with 17% EPS and 22% revenue growth. Its $140 billion EBITDA should make it worth more than Anthropic, which has none, though that comparison could be wrong. If distribution is king, Meta Muse could benefit from Meta's 3.64 billion daily active users, according to GuruFocus News. x.com  x.com  x.com